Abstract
Nature often produces compounds with a high degree of symmetry to reduce structural information and complexity. Synthesis of identical twin drugs, through the linkage of two identical pharmacophoric entities, is a classical strategy to produce more potent and/or selective drugs. Herein, two units of the privileged core of the coumarin hymecromone were linked together using “click chemistry”. Synthesis of 1-[2-(4-Methyl-7-coumarinyloxy)ethyl]-4-(5-{1-[2-(4-methyl-7-coumarinyloxy)ethyl]-1H-1,2,3-triazol-4-yl}pentyl)-1H-1,2,3-triazole was achieved by coupling of two identical units of an azido coumarin with a symmetrical alkine using copper(I)-catalyzed alkyne-azide cycloaddition reaction, in good yields and with complete regioselectivity.
1. Introduction
Aiming to reduce structural information and complexity, nature often produces compounds with a high degree of symmetry, as observed for the macromolecules HIV protease, hemoglobin and insulin. The linkage of two identical pharmacophoric entities, generating an “identical twin drug” or homodimer derivative, is a classical strategy used in medicinal chemistry to produce more potent and/or selective drugs compared to the single entities. These new compounds will have specific pharmacokinetic and pharmacodynamic properties, which normally differ from what it would be expected by simple doubling the dose of the drug [1].
Coumarins are a large class of compounds that display a wide variety of interesting biological properties [2,3,4,5,6,7], being their 2H-chromen-2-one nuclei the structural feature responsible for this “privileged” pharmacological profile. This planar ring system is composed by one aromatic ring, capable of establishing hydrophobic, π-π, CH-π and cation-π interactions, and one lactone ring, which contains two oxygen atoms that may interact via hydrogen bonding with a series of amino acid residues, such as serine, threonine, cysteine, asparagine, glutamine, and tyrosine [8].
In order to explore the possibility of potency and selectivity enhancements provided by the synthesis of twin drugs, two units of the privileged 2H-chromen-2-one nuclei of hymecromone (7-hydroxy-4-methylcoumarin) were linked together using “click chemistry”, a set of highly efficient conjugation reactions commonly used to join two or more entities [9].
2. Experimental Section
2.1. General Information
All chemicals were purchased as reagent grade and used without further purification. Solvents were distilled and/or dried according to standard methods [11]. Column chromatography was performed on silica gel 60 (0.040–0.063 mm) using CH2Cl2 and CH2Cl2/EtOAc (5:1 v/v or 2:1 v/v). Microwave-assisted reactions were performed on a CEM Discover® Microwave System. Melting points were determined on a Fisatom 431 apparatus, which were uncorrected. MS spectra were recorded on Q-Tof micro Waters high resolution mass spectrometer, operating in electrospray ionization mode. Nuclear magnetic resonance spectra were recorded on Bruker Advance DPX 400 (400 MHz) spectrometer. Chemical shifts (δ) are given in parts per million downfield from tetramethylsilane. 7-(2-Azidoethoxy)-4-methyl-2H-chromen-2-one (1) was synthesized according to reported methods [10] and coupled with commercial 1,8-nonadiyne (2) by using the copper(I)-catalyzed alkyne-azide cycloaddition reaction, in good yields and with complete regioselectivity (Scheme 1).
Scheme 1.
Synthesis of 1-[2-(4-Methyl-7-coumarinyloxy)ethyl]-4-(5-{1-[2-(4-methyl-7-coumarinyloxy)ethyl]-1H-1,2,3-triazol-4-yl}pentyl)-1H-1,2,3-triazole. Reagents, conditions and yields: (a) CuSO4, sodium ascorbate, DMF, MW 70 °C (18 W), 40 min (67%).
2.2. Synthesis of 1-[2-(4-Methyl-7-coumarinyloxy)ethyl]-4-(5-{1-[2-(4-methyl-7-coumarinyloxy)ethyl]-1H-1,2,3-triazol-4-yl}pentyl)-1H-1,2,3-triazole (3)
1,8-nonadiyne (2) (0.15 mL, 1.1 equiv) was added to a solution of 1 in DMF (0.5–1 M, 0.1 mL) in a microwave flask (0.2 mL) equipped with a stirring bar. Sodium ascorbate (0.1 equiv) and CuSO4 (0.03 equiv) were added, the tube was sealed, and the mixture was stirred for 25 seconds at room temperature, followed by heating under microwave irradiation at 70 °C (18 W) in 2 cycles of 20 min. Consumption of the reactant was followed by TLC (CH2Cl2/EtOAc 2:1 v/v). The reaction mixture was partitioned between H2O and EtOAc, the aqueous phase was extracted with EtOAc three times. The organic phase was dried over MgSO4, filtered, concentrated, and the residue purified by column chromatography with a CH2Cl2/EtOAc gradient [10]. Yield 67%; mp 168 °C; 1H NMR (400 MHz, DMSO-d6) δ 7.90 (s, 2H), 7.64 (d, 2H, J 8.8 Hz), 6.96 (d, 2H, J 2.6 Hz), 6.91 (dd, 2H, J 8.8, 2.6 Hz), 6.19 (d, 2H, J 1.2 Hz), 4.73 (t, 4H, J 5.0 Hz), 4.50 (t, 4H, J 5.0 Hz), 2.57 (t, 4H, J 7.6 Hz), 2.36 (d, 6H, J 1.2 Hz), 1.57 (quint, 4H, J 7.6 Hz), 1.31 (quint, 2H, J 7.6 Hz); 13C NMR (100 MHz, DMSO-d6) δ 160.9, 160.1, 154.6, 153.4, 146.9, 126.5, 122.4, 113.5, 112.5, 111.4, 101.4, 66.9, 48.7, 28.7, 28.1, 24.9, 18.1; HRMS (ESI) m/z, calcd. for C33H35N6O6 [M + H]+: 611.2573, found: 611.3377.
Supplementary Materials
Supplementary File 1Supplementary File 2Supplementary File 3Supplementary File 41H, 13C-NMR and HRMS spectra for compound 3 and the molfiles can be found at http://www.mdpi.com/1422-8599/2016/2/M894.
Acknowledgments
The authors thank the Brazilian funding agencies CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico), FAPERGS (Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul), FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paulo), and Instituto Nacional de Ciência e Tecnologia para Inovação Farmacêutica (INCT-IF) for the financial support. The authors are thankful to Prof. Saulo Fernandes de Andrade (PPGCF/UFRGS) and Prof. Francisco Paulo dos Santos (IQ/UFRGS) for the support on the NMR analyses and to Maristela Cabral da Silva Piedade (LaSOM/UFRGS) and Maribete Homrich Holzschuh (PPGCF/UFRGS) for the technical support.
Author Contributions
Fernando Torres, Gabriel Azambuja, Itamar Gonçalves and Guilherme Gonçalves: experimental work; Gilsane von Poser, Daniel Kawano and Vera Eifler: literature search, design of the synthesis and writing of the paper.
Conflicts of Interest
The authors declare no conflict of interest.
References
- Contreras, J.M.; Sippl, W. Homo and heterodimer ligands: The twin drug approach. In The Practice of Medicinal Chemistry, 3nd ed.; Wermuth, C.G., Ed.; Academic Press: London, UK, 2008; pp. 380–414. [Google Scholar]
- Gómez-Outes, A.; Suárez-Gea, M.L.; Calvo-Rojas, G.; Lecumberri, R.; Rocha, E.; Pozo-Hernández, C.; Terleira-Fernández, A.I.; Vargas-Castrillón, E. Discovery of anticoagulant drugs: A historical perspective. Curr. Drug Discov. Technol. 2012, 9, 83–104. [Google Scholar] [CrossRef] [PubMed]
- Matos, M.J.; Viña, D.; Vazquez-Rodriguez, S.; Uriarte, E.; Santana, L. Focusing on new monoamine oxidase inhibitors: Differently substituted coumarins as an interesting scaffold. Curr. Top. Med. Chem. 2012, 12, 2210–2239. [Google Scholar] [CrossRef] [PubMed]
- Vianna, D.R.; Bubols, G.; Meirelles, G.; Silva, B.; Rocha, A.; Lanznaster, M.; Monserrat, J.S.; Garcia, S.C.; von Poser, G.; Eifler-Lima, V.L. Evaluation of the antioxidant capacity of synthesized coumarins. Int. J. Mol. Sci. 2012, 13, 7260–7270. [Google Scholar] [CrossRef] [PubMed]
- Vianna, D.; Hamerski, L.; Figueiró, F.; Bernardi, A.; Visentin, L.; Teixeira, H.; Pires, E.; Eifler-Lima, V.L.; Salbego, C.; Batasttini, A.M.; et al. Selective cytotoxicity and apoptosis induction in glioma cell lines by 5-oxygenated-6,7-methylenedioxycoumarins from Pterocaulon species. Eur. J. Med. Chem. 2012, 57, 268–274. [Google Scholar] [CrossRef] [PubMed]
- Vianna, D.R.; Ruschel, L.; Dietrich, F.; Figueiró, F.; Morrone, F.B.; Canto, R.F.S.; Corvello, F.; Velho, A.; Crestani, A.; Teixeira, H.; et al. 4-Methylcoumarins with cytotoxic activity against T24 and RT4 human bladder câncer cell lines. MedChemComm 2015, 6, 905–911. [Google Scholar] [CrossRef]
- Matos, M.J.; Vazquez-Rodriguez, S.; Santana, L.; Uriarte, E.; Fuentes-Edfuf, C.; Santos, Y.; Muñoz-Crego, A. Looking for new targets: Simple coumarins as antibacterial agents. Med. Chem. 2012, 8, 1140–1145. [Google Scholar] [PubMed]
- Torres, F.C.; Brucker, N.; Andrade, S.F.; Kawano, D.F.; Garcia, S.C.; Poser, G.L.V.; Eifler-Lima, V.L. New insights into the chemistry and antioxidant activity of coumarins. Curr. Top. Med. Chem. 2014, 14, 2600–2623. [Google Scholar] [CrossRef] [PubMed]
- Aragão-Leoneti, V.; Campo, V.L.; Gome, A.S.; Field, R.A.; Carvalho, I. Application of copper(I)-catalysed azide/alkyne cycloaddition (CuAAC) “click chemistry” in carbohydrate drug and neoglycopolymer synthesis. Tetrahedron 2010, 66, 9475–9492. [Google Scholar] [CrossRef]
- Torres, F.C.; Goncalves, G.A.; Vanzolini, K.L.; Merlo, A.A.; Gauer, B.; Garcia, S.C.; Carvalho, I.; Poser, G.L.V.; Kawano, D.F.; Eifler-Lima, V.L.; et al. Combining the pharmacophore features of coumarins and 1,4-substituted 1,2,3-triazoles to design new acetylcholinesterase inhibitors: Fast and easy generation of 4-methylcoumarins/1,2,3-triazoles conjugates via click chemistry. J. Braz. Chem. Soc. 2016, in press. Available online: http://dx.doi.org/10.5935/0103-5053.20160033 (accessed on 8 February 2016). [Google Scholar]
- Armarego, W.L.F.; Chai, C.L.L. Purification of Laboratory Chemicals, 5th ed.; Butterworth-Heinemann: Burlington, VT, USA, 2003. [Google Scholar]
© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).